If you are developing a supplement or nutraceutical for the Australian market, there is one step you cannot skip — listing it on the Australian Register of Therapeutic Goods (ARTG). Without an ARTG listing, you cannot legally sell your product in Australia. No listing, no launch.
But the process is not as straightforward as filling in a form. There are regulatory pathways to choose, ingredient restrictions to navigate, and compliance requirements that can delay your launch by months if you get them wrong.
This guide walks you through how ARTG listing actually works, what most brands get wrong, and how to approach it without unnecessary delays or costs.
What Is the ARTG?
The ARTG is the official register maintained by the Therapeutic Goods Administration (TGA) — the Australian government body responsible for regulating therapeutic goods including prescription medicines, medical devices, and complementary medicines such as supplements.
Every therapeutic good sold in Australia must be included on the ARTG before it can be supplied. This applies whether you are an Australian brand manufacturing locally or an overseas brand importing into the Australian market.
Listed Medicine vs Registered Medicine: Which Pathway Do You Need?
This is the first decision you need to make, and it is the one most new brands get confused by.
The pathway for lower-risk products containing pre-approved ingredients from the TGA's list of permitted ingredients. Most supplements — vitamins, minerals, herbal extracts, probiotics — fall into this category. The assessment process is largely self-certified, meaning you are responsible for holding evidence that your product meets all requirements. The TGA does not review your evidence before listing, but they can audit you at any time.
For higher-risk products or products making specific therapeutic claims (for example, claiming a product treats or prevents a disease). The assessment is more rigorous, more expensive, and takes significantly longer. Most supplement brands do not need this pathway.
A middle pathway for listed medicines that want to make higher-level (intermediate) health claims. The TGA assesses the evidence before listing. Less common but relevant for brands wanting to differentiate with stronger marketing claims.
For the majority of supplement brands launching in Australia, AUST L is the correct pathway.
Key Requirements for an AUST L Listing
Before you can submit your application, you need to have the following in place.
Every ingredient in your product must appear on the TGA's Permissible Ingredients list, at a dose that falls within approved limits. This includes active ingredients and excipients. If any ingredient is not on the permitted list, your product cannot be listed as AUST L — you will need to either reformulate or apply through a different pathway.
Your product must be manufactured at a facility that holds TGA GMP (Good Manufacturing Practice) clearance. This applies to both Australian and overseas manufacturers. If your manufacturer does not have a TGA GMP Clearance ID, your application cannot proceed. This is one of the most common blockers for brands — particularly those manufacturing overseas.
Even though the TGA does not review your evidence before listing, you must hold it. This means clinical or scientific evidence supporting every health claim on your label and marketing material. The level of evidence required depends on the type of claim — general wellbeing claims require less evidence than specific health claims.
Your label must meet TGA requirements, including the correct AUST L number (once listed), mandatory warning statements, ingredient declarations, directions for use, and sponsor details. Getting labelling wrong is one of the fastest ways to trigger a TGA compliance review.
Every product on the ARTG must have an Australian sponsor — a person or company based in Australia who takes legal responsibility for the product. If you are an overseas brand, you will need to appoint an Australian sponsor.
The Application Process: Step by Step
Determine whether your product fits AUST L, AUST L(A), or AUST R based on your ingredients and intended claims.
Cross-check every ingredient (actives and excipients) against the TGA's Permissible Ingredients database. Confirm that your dosages fall within permitted limits.
Confirm that your chosen manufacturer holds a current TGA GMP Clearance. If they do not, this needs to be resolved before you can proceed — and obtaining GMP clearance is a separate, often lengthy process.
Compile the scientific evidence supporting your product's formulation, safety, and claims. Even though this is self-assessed, treat it as if the TGA will review it tomorrow — because they can.
Ensure your label meets all TGA requirements before submission.
Log into the TGA portal, navigate to Applications, select Listed Medicine, then General Listed, and follow the prompts. You will need to pay the application fee at this stage.
Once processed (typically within days for straightforward AUST L applications), your product is listed on the ARTG and you can legally supply it in Australia.
Common Mistakes That Delay ARTG Listings
The single most common reason listings stall. Many overseas manufacturers claim to be GMP-compliant, but GMP compliance and TGA GMP clearance are not the same thing. Always verify the clearance ID directly.
Some ingredients that are perfectly legal in the US or EU are not on the TGA's permitted list. Assuming international compliance equals Australian compliance is a costly mistake.
The TGA conducts post-market reviews and advertising audits. Brands that list products with unsupported claims risk having their listing cancelled and facing significant penalties.
TGA labelling rules are specific and detailed. Generic international labels almost never meet Australian requirements without modification.
Overseas brands sometimes begin the process without realising they need an Australian-based sponsor, adding weeks or months to their timeline.
When to Engage a Formulation Consultant
If you are developing a new product from scratch, a formulation consultant can save you significant time and money by ensuring your formula is TGA-compliant from the start — rather than discovering issues at the application stage.
A consultant can also help you navigate ingredient selection (choosing permitted ingredients that actually deliver efficacy), manufacturer sourcing (identifying facilities with confirmed TGA GMP clearance), evidence requirements (understanding what level of evidence your claims require), and labelling compliance.
The cost of getting expert guidance upfront is almost always less than the cost of reformulating, re-labelling, or resubmitting after a compliance failure.
Summary
Listing a supplement on the ARTG is not inherently complicated, but it requires precision. The brands that launch smoothly are the ones that get their formulation, manufacturer, and compliance ducks in a row before they touch the TGA portal — not after.
If you are developing a supplement for the Australian market and want to ensure your formulation and regulatory strategy are sound from the start, Formulyn offers a free 30-minute discovery call to scope your project.
Book a discovery call →Formulyn is a boutique nutraceutical and cosmetic formulation consultancy based in Brisbane, Australia, serving clients across Australia, Ireland, Singapore, and Southeast Asia.